Pliant Therapeutics, Inc. Price Today
Pliant Therapeutics, Inc.
PLRX
Healthcare
$801.78M
💰
Market Cap
0
💸
Price to Earnings
$-2.7
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Strong_buy Consensus
Buy |
10 |
Strong Buy |
9 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
PLRX Price Forecast Target
13.4 👉 63.0 +370%
PLRX EPS Forecast
-2.7 👉 -3.5 +27%
Financials
Profit Margin
0 %
Revenue Growth
-95.0 %
Dividend
$ 0
Held Percent
5.9% - Insiders
98.0% - Institutions
-3.9% - Public
Major Fund Holders
-
💰 Blackrock Inc. $79.9M
-
💰 FMR, LLC $76.9M
-
💰 Deep Track Capital, Lp $73.4M
-
💰 Laurion Capital Management, LP $57.2M
-
💰 Chi Advisors Llc $56.5M
Stock Ideas
Elon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extr…
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.📮FAQ
Some Frequently Asked Questions.
The Pliant Therapeutics, Inc. industry is Biotechnology
The Pliant Therapeutics, Inc. sector is Healthcare
The Pliant Therapeutics, Inc. forecasted predicted Price to Earnings PE ratio is -3.9
The Pliant Therapeutics, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Pliant Therapeutics, Inc. is $801.78M
There are total of 45754536 float shares with 98.0% held by Institutions and 5.9% held by insiders
The MPliant Therapeutics, Inc. forecasted Earnings per Share EPS is $-3.5
The Pliant Therapeutics, Inc. Earnings per Share EPS is -2.7
The Pliant Therapeutics, Inc. company has $9685000 gross profits with 0 profit margins
The Pliant Therapeutics, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Pliant Therapeutics, Inc. Revenue is $5027000 with -0.95 revenue growth
The price target for Pliant Therapeutics, Inc. stock is $63.0 for the high target and $24.0 for the low target
The consensus analyst recommendations for Pliant Therapeutics, Inc. is Strong_buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Pliant Therapeutics, Inc. is Strong_buy, with the following breakdown:
- Buy: 10
- Strong Buy: 9
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of Pliant Therapeutics, Inc. is 1.2
The dividend of Pliant Therapeutics, Inc. is $0
The dividend yield of Pliant Therapeutics, Inc. is 0%
The biggest institutional and mutual fund holders of Pliant Therapeutics, Inc. stock are
- Blackrock Inc.
- FMR, LLC
- Deep Track Capital, Lp
- Laurion Capital Management, LP
The Pliant Therapeutics, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0